Identification of a Chemotherapeutic Lead Molecule for the Potential Disruption of the FAM72A-UNG2 Interaction to Interfere with Genome Stability, Centromere Formation, and Genome Editing
Overview
Authors
Affiliations
Family with sequence similarity 72 A (FAM72A) is a pivotal mitosis-promoting factor that is highly expressed in various types of cancer. FAM72A interacts with the uracil-DNA glycosylase UNG2 to prevent mutagenesis by eliminating uracil from DNA molecules through cleaving the N-glycosylic bond and initiating the base excision repair pathway, thus maintaining genome integrity. In the present study, we determined a specific FAM72A-UNG2 heterodimer protein interaction using molecular docking and dynamics. In addition, through in silico screening, we identified withaferin B as a molecule that can specifically prevent the FAM72A-UNG2 interaction by blocking its cell signaling pathways. Our results provide an excellent basis for possible therapeutic approaches in the clinical treatment of cancer.
Chi H, Gao X, Xia Z, Yu W, Yin X, Pan Y Front Mol Biosci. 2023; 10:1200335.
PMID: 37275958 PMC: 10235772. DOI: 10.3389/fmolb.2023.1200335.
Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations.
Bai Y, Cao K, Zhang P, Ma J, Zhu J Int J Mol Sci. 2023; 24(1).
PMID: 36613817 PMC: 9820597. DOI: 10.3390/ijms24010375.
Zhou Q, Chen L, Yang L, Zhou H, Chen Y, Guo Y Front Oncol. 2022; 12:1046473.
PMID: 36483027 PMC: 9723133. DOI: 10.3389/fonc.2022.1046473.
Stewart J, Bhagwat A DNA Repair (Amst). 2022; 118:103381.
PMID: 35908367 PMC: 10996437. DOI: 10.1016/j.dnarep.2022.103381.